MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen General and Administrative Expenses 2011-2026 | INGN
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.4 M | 72.6 M | 75.3 M | 43.9 M | 37.9 M | 38.6 M | 37.1 M | 38 M | 37.6 M | 31.8 M | 25.7 M | 17.9 M | 13.8 M | 8.29 M | 5.62 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75.3 M | 5.62 M | 36.8 M |
Quarterly General and Administrative Expenses Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.2 M | 16.9 M | 16.2 M | - | 19.3 M | 18.6 M | 17.1 M | - | 17 M | 14.6 M | 18.9 M | - | 14.8 M | 12.7 M | 15.2 M | - | 9.26 M | 5.22 M | 12.5 M | - | 8.59 M | 9.72 M | 9.78 M | - | 8.52 M | 8.84 M | 9.68 M | - | 9.98 M | 9.68 M | 9.57 M | - | 10.4 M | 9.86 M | 8.34 M | - | 8.7 M | 7.24 M | 7.87 M | - | 6.41 M | 6.94 M | 5.72 M | - | 4.7 M | 3.91 M | 4.05 M | - | 3.53 M | 3.43 M | 2.83 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.3 M | 2.83 M | 10.4 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Profound Medical Corp.
PROF
|
10.3 M | $ 5.82 | 13.01 % | $ 180 M |  Canada |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.2 | 2.45 % | $ 330 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
806 K | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
2.72 B | - | - | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
39.3 M | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 2.16 | 7.46 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
717 M | $ 9.55 | 0.1 % | $ 735 M | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
IRadimed Corporation
IRMD
|
17.8 M | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Cytosorbents Corporation
CTSO
|
35 M | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
3.24 M | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 63.3 | 1.44 % | $ 3.45 B | Britain |
 |
InspireMD
NSPR
|
20.7 M | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
LENSAR
LNSR
|
26.5 M | $ 5.58 | 0.36 % | $ 64.3 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
663 M | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Medtronic PLC
MDT
|
10.8 B | $ 87.89 | 1.51 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
56.5 M | $ 4.1 | -0.73 % | $ 606 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
22.5 M | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Myomo
MYO
|
14 M | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
NanoVibronix
NAOV
|
3.46 M | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Orthofix Medical
OFIX
|
554 M | $ 11.93 | 1.79 % | $ 472 M |  Curacao |